Menu

VHP4Safety Models

Explore models generated or used in VHP4Safety and hosted on FAIRdom or BioModels archive.

S-VHPS18 study
Intestinal absorption of pesticides across Caco-2 cell monolayers
Released: 2026-06-01
View RO-Crate
S-VHPS17 study
TempO-Seq transcriptomics of iPSC-derived proximal tubular-like and endothelial-like cell mono- and co-cultures
Released: 2026-06-01
View RO-Crate
S-VHPS22 study
Neural cell screening models for endocrine disruption of thyroid hormone signaling
Released: 2026-05-27
View RO-Crate
S-VHPS16 study
Exposure matters: the impact of in vitro exposure scenarios
Released: 2026-05-25
View RO-Crate
S-VHPS23 study
Tacrolimus-induced nephrotoxicity in iPSC-derived kidney organoids
Released: 2026-03-18
View RO-Crate
S-VHPS24 study
Tacrolimus-induced nephrotoxicity in proximal tubule cells sorted from iPSC-derived kidney organoids
Released: 2026-03-18
View RO-Crate
S-VHPS27 study
Cell model comparison in the context of in vitro Parkinson studies
Released: 2026-03-18
View RO-Crate
S-VHPS25 study
Tacrolimus-induced nephrotoxicity in tubuloids
Released: 2026-03-18
View RO-Crate
S-VHPS26 study
Inhibition of OATP1C1-mediated cellular uptake of thyroxine
Released: 2026-03-18
View RO-Crate
S-VHPS28 study
Quantitative assessment of KEs in AOP464 Parkinson's disease
Released: 2026-03-18
View RO-Crate
S-VHPS20 study
Effect of three triiodothyronine (T3) conditions on neuronal differentiation of human embryonic stem cell derived neural progenitors
Released: 2026-03-18
View RO-Crate
S-VHPS21 study
Inhibition of MCT8-mediated cellular uptake of triiodothyronine in an overexpressing cell model
Released: 2025-11-10
View RO-Crate